MSD-MAP: A Network-Based Systems Biology Platform for Predicting Disease-Metabolite Links.

Henri Wathieu1, Naiem T Issa1, Manisha Mohandoss2

  • 1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC 20057. United States.

Summary

This study developed MSD-MAP to predict cancer-associated metabolites for colorectal, esophageal, and prostate cancers. The platform successfully identified known metabolite-disease links, aiding in understanding cancer mechanisms.